Fibromyalgia
A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
Drugs by status
Approved for this indication (6)
Phase 4 trials (22)
Phase 3 trials (18)
Phase 2 trials (43)
- nitrous oxide
- metformin
- ad 337
- acetylcysteine
- asp0819
- bacille calmette-guerin
- nabilone
- d-ribose
- cycloserine
- droxidopa
- eplivanserin
- eslicarbazepine acetate
- ferric carboxymaltose
- fremanezumab
- ibutamoren
- icosapent ethyl
- imc-1
- carbidopa
- neurotropin
- nyx-2925
- propranolol
- sitagliptin
- rotigotine
- ropinirole
- estradiol
- asp8062
- human fecal microbiota
- lacosamide
- mirtazapine
- faxeladol
- +13 more
Phase 1 trials (9)
Other trials (43)
- agomelatine
- calcium carbonate
- beta carotene
- Casopitant
- capsaicin
- chitosan
- ketamine
- citalopram
- egg
- l-glutamine
- esketamine
- levetiracetam
- magnesium oxide
- bromocriptine
- magnesium sulfate
- tyrosine
- glucose
- thiamine
- curcumin
- creatine
- gluten
- polyclonal avian immunoglobulin igy containing specific igy against e. coli f18ab and s. typhimurium
- inactivated influenza vaccine
- dexmedetomidine
- vsl #3
- amisulpride
- amino acids
- oxygen
- chickpea
- soybean
- +13 more
Organizations
Organization Involved with Phase 4 Indications (53)
- Eisai
- Cephalon
- AstraZeneca
- Sanofi
- Allergan
- GlaxoSmithKline
- Sunovion
- Yung Shin Pharm. Ind. Co., Ltd.
- Boehringer Ingelheim
- Dr Alexander McIntyre Inc.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- University of Pittsburgh
- Albany Medical College
- Cleveland Sleep Research Center
- East Tennessee State University
- Duke University
- Grupo Rehabilitacion en Salud
- Henry Ford Health System
- Indiana University
- Loma Linda University
- Newton-Wellesley Hospital
- Osteoporosis Medical Center, Beverly Hills, CA
- Rutgers University
- Tufts University
- Unidad de Investigacion en Enfermedades Cronico-Degenerativas
- Universidad Autonoma de Nuevo Leon
- Universidad de Antioquia
- University of Medicine and Dentistry of New Jersey
- University of Michigan
- State University of New York
- +23 more
Organization Involved with Phase 3 Indications (41)
- Pierre Fabre
- Jazz Pharmaceuticals
- Daiichi Sankyo
- Merck
- Merck KGaA
- Shionogi
- Ipsen
- Wyeth
- Hengrui Therapeutics, Inc.
- INC Research
- Fundacio Lluita Contra la SIDA
- University of Arizona
- Aragon Institute of Health Sciences
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Cornell University
- Harvard University
- Federal University of Health Science of Porto Alegre
- Federal University of Rio Grande do Sul
- University of Washington
- Good Samaritan Regional Medical Center, Oregon
- Mahatma Gandhi Institute of Medical Sciences
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Wake Forest University
- University of Cincinnati
- Icahn School of Medicine at Mount Sinai
- Tonix Pharmaceuticals
- Badalona Hospital Germans Trias i Pujol
- University of Limoges
- Hospital Egas Moniz
- Touro University
- +11 more
Organization Involved with Phase 2 Indications (38)
- Zars Pharma Inc.
- Chelsea Therapeutics
- Theravance
- Bausch Health Companies
- Grunenthal
- Astellas
- Aptinyx
- Virios Therapeutics
- RiboCor, Inc.
- Sosei
- Teva
- National Institutes of Health (NIH)
- National Institute of Nursing Research (NINR)
- Winnipeg Regional Health Authority
- University of Manitoba
- University of London
- Deakin University
- Hoosier Cancer Research Network
- Julius-Maximilians University
- Mahidol University
- Mansoura University
- McGill University
- Oregon Health and Science University
- University of Kentucky
- University of Kiel
- University of Rochester
- University of Southern Denmark
- Columbia University
- Vanderbilt University
- Woodinville Psychiatric Associates
- +8 more
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (38)
- Bioenergy Life Science, Inc.
- ESM Technologies, LLC
- IgNova GmbH
- Lescuyer Laboratory
- Alexandria University
- China Academy of Chinese Medical Sciences
- Federal University of Minas Gerais
- Haydarpasa Numune State Hospital
- Ostergotland County Council, Sweden
- Stanford University
- The Center for Clinical Research, Winston-Salem, NC
- Yonsei University
- Mayo Clinic
- Kona Research Center
- University of California, Davis
- University of California, San Francisco
- Universidad de Almeria
- Hebrew University
- University of Lyon
- Technion University
- Free University of Brussels
- The Annapolis Center for Effective CFS/Fibromyalgia Therapies
- Linkoping University
- CHU Charleroi
- SCOPE International AG
- Klinar CRO
- CenTrial GmbH
- Pharmasolutions4U
- Artesis University College
- Integrative Therapeutics, Inc.
- +8 more